Bitcoin's recent sell-off has been quite aggressive, but on-chain metrics suggest downward pressure is not nearly as drastic as the…
McAlinden Research PartnersJanuary 11, 2022
Paired with a double dose of tapering, the FOMC’s latest updating of interest rate projections indicate a much more hawkish…
McAlinden Research PartnersDecember 23, 2021
Most data indicates M&A activity has slowed in the pharmaceutical and biotech industries. However, that may change in 2022 as…
McAlinden Research PartnersDecember 22, 2021
Following another round of missed coupon payments by China's Evergrande, default is looking more inevitable than ever. A long road…
McAlinden Research PartnersDecember 8, 2021
The new Omicron variant of COVID-19 has spurred a broader sell off in equities, but poses little threat of endangering…
McAlinden Research PartnersDecember 7, 2021
As gas and coal prices have broken out to multi-year highs this year, utility-scale solar projects continue to get cheaper. Lower…
McAlinden Research PartnersNovember 30, 2021
US drug store chains are set to experience heightened foot traffic now that all adults are eligible for booster shots…
McAlinden Research PartnersNovember 29, 2021
Play-to-earn digital assets have surged in recent months as the future of gaming and blockchain technologies have begun to converge within the…
McAlinden Research PartnersNovember 23, 2021
The plant-based food boom is showing signs of slowing. Beyond Meat recently announced lackluster earnings. Growth has fallen well below breakout rates…
McAlinden Research PartnersNovember 22, 2021
